Analysis of bleeding complications associated with glycoprotein IIb/IIIa receptors blockade in patients with high-risk acute coronary syndromes: Insights from the PRISM-PLUS study
- 8 April 2005
- journal article
- research article
- Published by Elsevier
- Vol. 100 (1) , 73-78
- https://doi.org/10.1016/j.ijcard.2004.07.014
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Is glycoprotein IIb/IIIa antagonism as effective in women as in men following percutaneous coronary intervention?: Lessons from the ESPRIT studyJournal of the American College of Cardiology, 2002
- Benefits and Safety of Tirofiban Among Acute Coronary Syndrome Patients With Mild to Moderate Renal InsufficiencyCirculation, 2002
- Clinical benefit of glycoprotein IIb/IIIa blockade with abciximab is independent of genderJournal of the American College of Cardiology, 2000
- Inhibition of Platelet Glycoprotein IIb/IIIa with Eptifibatide in Patients with Acute Coronary SyndromesNew England Journal of Medicine, 1998
- Modifiable Risk Factors for Vascular Access Site Complications in the IMPACT II Trial of Angioplasty With Versus Without EptifibatideJournal of the American College of Cardiology, 1998
- A Comparison of Aspirin plus Tirofiban with Aspirin plus Heparin for Unstable AnginaNew England Journal of Medicine, 1998
- Inhibition of the Platelet Glycoprotein IIb/IIIa Receptor with Tirofiban in Unstable Angina and Non–Q-Wave Myocardial InfarctionNew England Journal of Medicine, 1998
- Platelet Glycoprotein IIb/IIIa Receptor Blockade and Low-Dose Heparin during Percutaneous Coronary RevascularizationNew England Journal of Medicine, 1997
- Impaired high‐shear‐stress‐induced platelet aggregation in patients with chronic renal failure undergoing haemodialysisBritish Journal of Haematology, 1995
- Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary AngioplastyNew England Journal of Medicine, 1994